Beasley Allen is spearheading the review of over 31,000 claims against the manufacturers of Bextra, Celebrex, and Vioxx, having filed 161 cases to date. Montgomery, AL ( PRWEB ) April 14, 2005 — Beasley, Allen, Crow, Methvin, Portis & Miles, P.C Read More

MONDAY, April 14 (HealthDay News) — Two widely used drugs — one lowers cholesterol and one is an anti-inflammatory — may be useful in controlling prostate cancer. New research being presented at the American Association for Cancer Research annual Read More

The new rules would bar government advisers who receive money from a drug or device maker from voting on that company’s products. Expert advisers to the government who receive money from a drug or device maker would be barred for the first time Read More

UNIDENTIFIED SPEAKER: Well, good morning, and welcome to the Pfizer session this morning. We’re very pleased to have with us Dr. Joe Feczko, who is Senior Vice President and Chief Medical Officer of Pfizer. Pfizer has one of the broadest and deepest Read More

This entry was posted on Saturday, June 28th, 2008 at 3:33 am and is filed under Bextra. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.